Drug Type Unknown |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization NaNotics LLCStartup |
Active Organization NaNotics LLCStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Cancer | Preclinical | US | NaNotics LLCStartup | 05 Dec 2023 |
Hodgkin's Lymphoma | Preclinical | US | NaNotics LLCStartup | 05 Dec 2023 |
Melanoma | Preclinical | US | NaNotics LLCStartup | 05 Dec 2023 |
Nasopharyngeal Carcinoma | Preclinical | US | NaNotics LLCStartup | 05 Dec 2023 |
Non-Hodgkin Lymphoma | Preclinical | US | NaNotics LLCStartup | 05 Dec 2023 |
Pancreatic Cancer | Preclinical | US | NaNotics LLCStartup | 05 Dec 2023 |
Sepsis | Preclinical | US | NaNotics LLCStartup | 05 Dec 2023 |
Stomach Cancer | Preclinical | US | NaNotics LLCStartup | 05 Dec 2023 |
Uterine Cervical Cancer | Preclinical | US | NaNotics LLCStartup | 05 Dec 2023 |
Well Aging | Preclinical | US | NaNotics LLCStartup | 05 Dec 2023 |